1. Introduction {#sec1-marinedrugs-14-00114}
===============

Glycosides are an important class of natural products discovered in higher plants and animals \[[@B1-marinedrugs-14-00114],[@B2-marinedrugs-14-00114],[@B3-marinedrugs-14-00114]\]. Sea cucumber saponins are triterpene glycosides isolated from holothuroids (Echinodermata), which consists of a sugar moiety composed of a maximum of six monosaccharides attached to a triterpene based on holostanol \[[@B4-marinedrugs-14-00114],[@B5-marinedrugs-14-00114]\]. With more and more recent papers describing saponins properties, sea cucumber saponins are reported to possess extensive physiological activities \[[@B6-marinedrugs-14-00114]\] including hemolytic, antitumoral, antifungal, anti-bacterial, antiviral, cytostatic, and immunoregulatory activity \[[@B7-marinedrugs-14-00114],[@B8-marinedrugs-14-00114],[@B9-marinedrugs-14-00114],[@B10-marinedrugs-14-00114],[@B11-marinedrugs-14-00114],[@B12-marinedrugs-14-00114],[@B13-marinedrugs-14-00114]\]. However, the pharmacological effect of sea cucumber saponins *in vivo* as an oral medicine depends on its bioavailability in humans. Our attention is focused on two sea cucumber saponins, Echinoside A and Holotoxin A~1~, isolated from *Apostichopus japonicus* which possess wide pharmacological effects, including antifungal, hemolytic, cytotoxic activity, increasing viscidity of cytomembrane, and decreasing lipids in serum \[[@B14-marinedrugs-14-00114]\].

Bioavailability represents the rate and extent of an oral dose reaching the blood circulation. It is controlled by the solubility and dissolution rate of a drug in the intestinal fluid and permeability across the intestinal membrane, pre-systemic metabolism and, sometimes, the efficiency of the drug transporting system \[[@B15-marinedrugs-14-00114]\]. In addition to an animal model, a number of *in vitro* and *in situ* experimental models have been developed to figure out the intestinal permeability of a drug and its mechanism, such as the Caco-2 cell model, single-pass intestinal perfusion, and everted gut sac \[[@B16-marinedrugs-14-00114],[@B17-marinedrugs-14-00114],[@B18-marinedrugs-14-00114]\].

Caco-2 cells originate from human colonic carcinoma. They can spontaneously differentiate into apical side and basolateral side (similarly to the villi and the base of the intestine), and form a monolayer under the culture condition *in vitro* \[[@B19-marinedrugs-14-00114],[@B20-marinedrugs-14-00114]\]. Similarly to the human small intestine, Caco-2 cells express several active transport systemers and marker enzymes \[[@B21-marinedrugs-14-00114],[@B22-marinedrugs-14-00114],[@B23-marinedrugs-14-00114]\]. Single-pass intestinal perfusion is the most frequently used technique, which provides the closest conditions to the *in vivo* oral administration \[[@B24-marinedrugs-14-00114],[@B25-marinedrugs-14-00114]\].

Previously, several studies about the absorption of plant saponins have been published. Jiang *et al.* \[[@B26-marinedrugs-14-00114]\] investigated the bioavailability of Soyasaponin, demonstrated that Soyasaponin I and Sapongenol B have limited absorption. Han *et al.* \[[@B27-marinedrugs-14-00114]\] indicated that transport across Caco-2 cell monolayer for panaxnotoginseng saponin is a simple passive diffusion process and no efflux transporters showed effects on it. Although new sea cucumber saponins with great physiological activity have been discovered successively \[[@B28-marinedrugs-14-00114]\], knowledge on the bioavailability of these compounds is limited.

Our study attempted to characterize the permeability of sea cucumber saponins in the intestine. We investigated the pharmacokinetics of two sea cucumber saponins, and analyzed the relationship between their bioavailability and their chemical structure. Caco-2 monolayer and single-pass intestinal perfusions were used to explore the transport mechanism of sea cucumber saponins.

2. Results {#sec2-marinedrugs-14-00114}
==========

2.1. Characterization of Echinoside A {#sec2dot1-marinedrugs-14-00114}
-------------------------------------

Echinoside A was isolated and identified by our research group. Its mass spectrum (MS) and nuclear magnetic resonance (NMR) data are shown in [Figure 1](#marinedrugs-14-00114-f001){ref-type="fig"} and [Table 1](#marinedrugs-14-00114-t001){ref-type="table"} and [Table 2](#marinedrugs-14-00114-t002){ref-type="table"}. This is the first characterization of this saponin in *Apostichopus japonicas*.

The chemical structure of Holotoxin A~1~ and Echinoside A are shown in [Figure 2](#marinedrugs-14-00114-f002){ref-type="fig"} and [Figure 3](#marinedrugs-14-00114-f003){ref-type="fig"}.

2.2. Method Validation {#sec2dot2-marinedrugs-14-00114}
----------------------

The retention times for Echinoside A and Holotoxin A~1~ were 16.2 and 28.3 min, respectively ([Figure 4](#marinedrugs-14-00114-f004){ref-type="fig"}).

### 2.2.1. Linearity and Sensitivity {#sec2dot2dot1-marinedrugs-14-00114}

The calibration curves were linear over the concentration range of 100--5000 ng/mL and 100--20,000 ng/mL for Echinoside A and Holotoxin A~1~ in Hank's balanced salt solution (HBSS) and rat plasma. The regression equation for the calibration curve of Echinoside A in HBSS and plasma were, respectively, *Y* = 528884*X* − 2318.7 (*r*^2^ = 0.9988) and *Y* = 30668*X* + 30.707 (*r*^2^ = 0.9991). The regression equation for the calibration curve of Holotoxin A~1~ in HBSS and plasma, were respectively, *Y* = 25428*X* − 301.05 (*r*^2^ = 0.9991) and *Y* = 25562*X* + 2171.8 (*r*^2^ = 0.9992). The lower limits of quantification (LLOQ) of Echinoside A and Holotoxin A~1~ in HBSS and rat plasma were found to be 100 ng/mL. The limit of detection (LOD) for Echinoside A and Holotoxin A~1~ in HBSS and plasma were both 50 ng/mL. Meanwhile, the calibration curves were linear over the concentration range of 500--15,000 ng/mL for Echinoside A and Holotoxin A~1~ in perfusate. The regression equation for the calibration curve of Echinoside A and Holotoxin A~1~ in perfusate were, respectively, *Y* = 39950*X* + 576.33 (*r*^2^ = 0.9990) and *Y* = 46916*X* + 1715.7 (*r*^2^ = 0.9989). The LLOQ of Echinoside A and Holotoxin A~1~ were found to be 500 ng/mL in perfusate. The LOD for Echinoside A and Holotoxin A~1~ in perfusate were 200 ng/mL.

### 2.2.2. Precision and Accuracy {#sec2dot2dot2-marinedrugs-14-00114}

The precision and accuracy data are shown in [Table 3](#marinedrugs-14-00114-t003){ref-type="table"}. The repeatability of the method was examined by both intra and inter-day repeatability. The intra and inter-day R.S.D.% of Echinoside A and Holotoxin A~1~ were less than 7.8% and 5.6%, and accuracy was ranged from −4.4% to 5.8%. The results indicated the stability and repeatability of the method for the quantitative determination of Echinoside A and Holotoxin A~1~.

### 2.2.3. Recovery and Stability {#sec2dot2dot3-marinedrugs-14-00114}

As shown in [Table 4](#marinedrugs-14-00114-t004){ref-type="table"}, the absolute recovery of Echinoside A and Holotoxin A~1~ in plasma were both above 90%. Two analytes were stable after frozen storage, analysis processing, and freeze-thaw conditions. The stability of Echinoside A and Holotoxin A~1~ in plasma and perfusate were 93.4%--102.4% and 88.2%--94.8% under three conditions, respectively ([Table 5](#marinedrugs-14-00114-t005){ref-type="table"}), which confirms the stability of Echinoside A and Holotoxin A~1~.

2.3. Pharmacokinetic Analysis of Sea Cucumber Saponins {#sec2dot3-marinedrugs-14-00114}
------------------------------------------------------

After oral administration, Echinoside A and Holotoxin A~1~ were present in blood with different levels. [Figure 5](#marinedrugs-14-00114-f005){ref-type="fig"}a shows the mean plasma concentrations-time profiles of Echinoside A. After oral administration, Echinoside A was detected at 1 h in rat plasma, which indicated that it could be gradually absorbed into plasma. Within 3 h, the concentration of Echinoside A in the plasma achieved the max value of 910 ng/mL. The elimination half-life time (*T*~1/2~) of Echinoside A was 6.99 h. On the contrary, no saponin was detected during the experiment (*i.e.*, 24 h). The relevant pharmacokinetic parameters are listed in [Table 6](#marinedrugs-14-00114-t006){ref-type="table"}.

After intravenous administration, Echinoside A and Holotoxin A~1~ were present in plasma and decreased gradually over time ([Figure 5](#marinedrugs-14-00114-f005){ref-type="fig"}b,c). The concentration-time curve of Echinoside A after intravenous administration included decreasing process only, whereas the concentration-time curve of Echinoside A after oral administration divided into increasing and decreasing trend. The relevant pharmacokinetic parameters are listed in [Table 6](#marinedrugs-14-00114-t006){ref-type="table"}. The area under the curve (AUC) and *C*~max~ of Echinoside A after intravenous administration were significantly higher (*p* \< 0.05) than Holotoxin A~1~.

Echinoside A and Holotoxin A~1~ exhibited different transport dynamics after oral and intravenous administration. The bioavailability of Echinoside A was 59%, meanwhile Holotoxin A~1~ was not detected in the plasma after oral administration. This finding revealed that the bioavailability of Holotoxin A~1~ was lower than Echinoside A.

2.4. Transport Experiments of the Caco-2 Cell Model {#sec2dot4-marinedrugs-14-00114}
---------------------------------------------------

The present study was undertaken to detect the transport of sea cucumber saponins with different concentrations over time. [Figure 6](#marinedrugs-14-00114-f006){ref-type="fig"} shows Echinoside A collected in the receiver chamber at 0, 60, and 150 min. The accumulation of different concentration of Echinoside A transported from apical-to-basolateral (AP-to-BL) ([Figure 6](#marinedrugs-14-00114-f006){ref-type="fig"}a) and from basolateral-to-apical (BL-to-AP) ([Figure 6](#marinedrugs-14-00114-f006){ref-type="fig"}b) increased linearly within 150 min. The results indicated that the cumulative amounts in the receiver chamber rose significantly (*p* \< 0.05) at the same time as the concentration of Echinoside A increased; meanwhile, the cumulative amounts in the receiver chamber in BL-AP direction were significantly higher (*p* \< 0.05) than the cumulative amounts in AP-BL direction at the same time in each concentration.

The absorption and transport of the drug in Caco-2 cell monolayer was evaluated by the apparent permeability coefficients (Papp). The PappAB (Papp (AP to BL) value) of Echinoside A (20 µM), Holotoxin A~1~ (20 µM) and two transcellular transport markers propranolol and atenolol are summarized in [Figure 7](#marinedrugs-14-00114-f007){ref-type="fig"}. [Figure 7](#marinedrugs-14-00114-f007){ref-type="fig"} indicated that the PappAB of Echinoside A was significantly higher (*p* \< 0.05) than atenolol, and significantly lower (*p* \< 0.05) than propranolol. The PappAB of Holotoxin A~1~ was significantly lower (*p* \< 0.05) than propranolol and Echinoside A.

The PappAB of Echinoside A was (3.96 ± 0.55) × 10^−6^ cm·s^−1^, which was about one sixth of that for propranolol, at (26.1 ± 1.2) × 10^−6^ cm·s^−1^; meanwhile, it was more than eight-fold higher than that for atenolol of (0.48 ± 0.07) × 10^−6^ cm·s^−1^. Holotoxin A~1~ was not detected in the receiver compartment, which indicated that Holotoxin A~1~ accumulated in the receiver compartment was less than the limit of detection; therefore, the PappAB of Holotoxin A~1~ was less than 0.83 × 10^−6^ cm·s^−1^.

At the same time, Echinoside A and Holotoxin A~1~ in the AP chambers and cells were detected to verify their stability. The percentage recovered in AP chambers, BL chambers, and cell monolayer are shown in [Table 7](#marinedrugs-14-00114-t007){ref-type="table"}. [Table 7](#marinedrugs-14-00114-t007){ref-type="table"} indicated that Echinoside A were present in AP chambers, BL chambers, and cell monolayer. Holotoxin A~1~ was present in AP chambers. The recovery revealed that they were stable in this model.

P-glycoprotein (P-gp) is expressed in the apical side of Caco-2 monolayers with verapamil as the classic inhibitor. The efflux ratio which is used to present the extent of excretion is calculated by efflux *versus* absorption (PappBA/PappAB). To investigate the present of exocytosis, transport experiment was examined in the presence and absence of verapamil (Sigma-Aldrich, St. Louis, MO, USA, 100 μM). [Table 8](#marinedrugs-14-00114-t008){ref-type="table"} showed the Papp value of Echinoside A (20 µM) and Holotoxin A~1~ (20 µM) in the absence and presence of verapamil. The lack of directional preference and no significant decrease of the efflux ratio compared to the data in the absence of the P-gp-inhibitor suggested that Echinoside A was transported by passive diffusion without the participation of P-gp.

We found that the Caco-2 cell model showed high and efficient transport of Echinoside A, and oppositely, poor transport of Holotoxin A~1~. The results were coincident with their transport dynamics parameters of pharmacokinetics.

2.5. Single-Pass Intestinal Perfusion of Sea Cucumber Saponins {#sec2dot5-marinedrugs-14-00114}
--------------------------------------------------------------

After the perfusion of different doses of Echinoside A and Holotoxin A~1~, their steady-state concentrations collected from the outlet were detected. The intestinal permeability of Echinoside A and Holotoxin A~1~ were determined by permeability across the intestinal membrane (Peff) value. The Peff of Echinoside A and Holotoxin A~1~ from *in situ* vascular perfusion were, respectively, 2.50 × 10^−5^ cm·s^−1^ and 2.67 × 10^−6^ cm∙s^−1^. The Peff values of each concentration are listed in [Figure 8](#marinedrugs-14-00114-f008){ref-type="fig"}.

Concentration-dependent changes of Echinoside A and Holotoxin A~1~ in permeability were not found in the segment of intestine. The permeability at 25 μg/mL of Echinoside A was close to that at 1 μg/mL. No significant increase in permeability of Echinoside A and Holotoxin A~1~ was tested when verapamil (400 μg/mL) was added to the perfusate, which indicated that P-gp did not affect the intestinal absorption of Echinoside A and Holotoxin A~1~.

The results of single-pass intestinal perfusion model on the absorption and metabolism of Echinoside A and Holotoxin A~1~ confirmed the results of pharmacokinetics experiments and transport experiments across Caco-2 model.

2.6. Formatting of Mathematical Components {#sec2dot6-marinedrugs-14-00114}
------------------------------------------

where, d*Q/*d*t* (nmol·s^−1^) represents the rate of the compound accumulated in the receiver compartment over time. *A* (cm^2^) represents the membrane area of the insert. *C*~0~ (nmol/cm^3^) represents the initial concentration of the drug in the donor compartment \[[@B29-marinedrugs-14-00114],[@B30-marinedrugs-14-00114],[@B31-marinedrugs-14-00114]\]. Data were expressed as the means ± SD of three determinations:

In which *C*~in~ is the inlet concentration and *C*~out~ is the outlet concentration of compound, which is corrected for volume change in the segment using phenol red concentration in the inlet and outlet tubing. *Q* is the flow rate (0.2 mL/min), *r* is the rat intestinal radius (0.18 cm), and *l* is the length of the segment \[[@B32-marinedrugs-14-00114]\].

3. Discussion {#sec3-marinedrugs-14-00114}
=============

The current study developed a highly-sensitive and effective HPLC method with evaporative light scattering detection to determine sea cucumber saponins. This method was validated to confirm high accuracy, precision, and reproducibility. This study highlighted the absorption and transport of two sea cucumber saponin monomers using the Caco-2 monolayer model, single-pass intestinal perfusion model, and *in vivo* pharmacokinetics in rats, and speculated the relationship between the chemical structure of two sea cucumber saponins and their bioavailability.

Echinoside A showed higher bioavailability than Holotoxin A~1~. Factors affect the bioavailability of drugs include structural and chemical properties of molecules, such as molecular weight, hydrogen performance, branched chain, and solubility. As a small molecular substance, sea cucumber saponins are neutral, liposoluble, but not hydrophobic. Compared with Holotoxin A~1~, Echinoside A has a lower molecular weight. Holotoxin A~1~ has six monosaccharides, which is two more than that of Echinoside A. Additionally, the six monosaccharides are divided into two branched chains, which results in larger steric hindrance. We speculate that these reasons lead to lower bioavailability of Holotoxin A~1~.

Artursson, Karlsson \[[@B33-marinedrugs-14-00114]\], and Lau \[[@B34-marinedrugs-14-00114]\] indicated that drugs with Papp ≥ 3 × 10^−6^ cm·s^−1^ represented high permeability and good absorption, while compounds with a Papp of less than about 2 × 10^−6^ cm·s^−1^ exhibited poor oral absorption. The results of the Caco-2 cell model and single-pass intestinal perfusion model showed high and efficient transport of Echinoside A, and oppositely, poor transport of Holotoxin A~1~, which confirmed the results of pharmacokinetics experiments, and demonstrated our conjecture that the differences in chemical structure between compounds was a factor that explained their different characteristics of transport across the intestine.

Jiang *et al.* \[[@B27-marinedrugs-14-00114]\] investigated the bioavailability of Soyasaponin, demonstrated that Soyasaponin I and Sapongenol B have limited absorption. Han *et al.* \[[@B27-marinedrugs-14-00114]\] used Caco-2 cells and rat models to study the mechanism of absorption after oral administration of panaxnotoginseng saponins (PNS). The results indicated that PNS showed low membrane permeability on Caco-2 cell monolayer and poor absorption. Our study indicated that Echinoside A exerted efficient transport on the Caco-2 cell monolayer and favorable bioavailability compared with plant saponins.

Processed sea cucumbers (trepangs) have a high commercial value and are consumed for food and traditional medicine in Asian communities. Caulier *et al.* \[[@B35-marinedrugs-14-00114]\] compared the saponins contained in the body wall of sea cucumbers and the trepangs. They found that saponins seem to be thermically resistant in the processed procedure which indicated that sea cucumbers saponins were stable as food.

Our work found a sea cucumber saponin monomer with high and efficient transport, which indicated that this secondary metabolite with extensive physiological activities can be absorbed efficiently by humans. This study lays a foundation for further study of the clinical application of sea cucumber saponins. In addition, our speculation about the relationship between the chemical structure of two sea cucumber saponins and their bioavailability could be verified by more sea cucumber saponins in the future studies and provided a method for direct assessment of the intestinal absorption of drug.

4. Materials and Methods {#sec4-marinedrugs-14-00114}
========================

4.1. Chemicals and Materials {#sec4dot1-marinedrugs-14-00114}
----------------------------

The human colon adenocarcinoma cell line, Caco-2, was obtained from the cell resource center of the Shanghai Institutes for Biological Sciences. Dulbecco's modified eagle medium (DMEM) and fetal bovine serum were from Gibco (Thermo Fisher, Shanghai, China), penicillin and streptomycin were from Sigma-Aldrich.

Sea cucumber saponins were separated and purified by our research group \[[@B36-marinedrugs-14-00114]\]. We used two saponin monomers (Holotoxin A~1~ and Echinoside A) which did not contain other molecules in our experiments. 15.5 kg sea cucumbers were used for extraction. The weight of extraction was 9.763 g. The productive rate of Holotoxin A~1~ and Echinoside A from the extraction were respectively about 6% and 4%.

Millicell hanging cell culture inserts (polyethylene terephthalate membrane, 0.33 cm^2^ surface, 0.4 μm pore size) were purchased from Corning (New York, NY, USA). All other chemicals used in this study were of analytical grade.

Hanks' buffered saline solution (HBSS) containing 10 mM HEPES and 25 mM D-(+)-glucose. Perfusate was Krebs-Ringer buffer solution containing (g/L) NaCl 7.8, KCl 0.35, CaCl~2~ 0.37, MgCl~2~ 0.22, NaH~2~PO~4~ 0.32, glucose 3.0, NaHCO~3~ 1.37, dextran 30, and BSA 50.

4.2. Animals {#sec4dot2-marinedrugs-14-00114}
------------

Male Wistar rats weighting 200--220 g were obtained from Qingdao Institute for Drug Control (Qingdao, China, SCXK2009007) and acclimated for 7 d in an environmentally-controlled room (temperature: 25 ± 2 °C, humidity: 50% ± 5%, 12 h dark-light cycle) with free access to water and food. All *in vivo* animal work was approved by Animal Ethics Committee of School of Medicine and Pharmacy, Ocean University of China. The rats were subjected to fasting, with access to water, for 12 h before the experiment in order to avoid the influence of the food to the absorption of sea cucumber saponins. Five rat individuals were used for each parallel control group.

4.3. Chromatographic Conditions {#sec4dot3-marinedrugs-14-00114}
-------------------------------

The content of sea cucumber saponins was tested by HPLC system (Waters Corp, Milford, MA, USA) consisting of a pump (Model 1525), an autosampler (Model 717), and an evaporative light-scattering detector (ELSD, Model 2420). Separations were performed on a Kromasil C18 (Zonran Technologies, Huaian, China) reversed-phase column (5 μm, 150 × 4.6 mm). The column temperature was set to 40 °C and the flow rate was 0.7 mL·min^−1^. The mobile phase consisted of double-distilled water (solution A) and acetonitrile (solution B), the acetonitrile gradient was 27% from 0 to 15 min, 27%--42% from 15 to 30 min, 42%--27% from 30 to 32 min. The carrier gas pressure of ELSD was 25 psi, the drift tube temperature was 60 °C, the atomization efficiency was 50% and the gain value was 25. These conditions were chosen according to the research of Zhang *et al.* \[[@B36-marinedrugs-14-00114]\].

4.4. Method Validation {#sec4dot4-marinedrugs-14-00114}
----------------------

Stock solutions of Echinoside A and Holotoxin A~1~ were prepared in water (1 mg/mL) and working standard solutions were prepared by serial dilution in HBSS, blank rat plasma, and blank perfusate, respectively. The plasma with the quality control (QC) sample was blended with methanol and centrifuged for 10 min at 15,000 rpm, the supernatant was dried under nitrogen and dissolved with methanol for analysis.

### 4.4.1. Linearity {#sec4dot4dot1-marinedrugs-14-00114}

The linearity of HPLC method for the determination of Holotoxin A~1~ and Echinoside A was evaluated by calibration curves. The calibration curves were obtained by plotting the chromatographic peaks area *versus* the concentrations of analytes prepared. The slope, intercept, and correlation coefficient of the calibration curves were determined by least squares linear regression analysis.

### 4.4.2. Precision and Accuracy {#sec4dot4dot2-marinedrugs-14-00114}

Five QC samples of different concentrations were injected on a single day (intra-day) and on three consecutive days (inter-day). The precision was expressed as the relative standard deviation (R.S.D.%) and the accuracy was expressed as the relative error (R.E.%).

### 4.4.3. Recovery and Stability {#sec4dot4dot3-marinedrugs-14-00114}

Five replicates of Holotoxin A~1~ and Echinoside A diluted to 100, 1000, and 5000 ng/mL by plasma and perfusate were detected, and the absolute recovery was determined by comparing the peak-area value from the calibration curve and the real concentration. Freeze-thaws, short-term, and long-term stabilities of Holotoxin A~1~ and Echinoside A in plasma and perfusate were verified using different concentrations of QC samples. In the freeze-thaw cycle, the samples were frozen and stored at −20 °C for 24 h, then thawed at ambient temperature. To evaluate long-term stability, samples were kept at ambient temperature for 5 d until extraction. For the short-term stability, samples were kept at ambient temperature for 24 h before extraction.

4.5. In Vivo Pharmacokinetics of Sea Cucumber Saponins in Rats {#sec4dot5-marinedrugs-14-00114}
--------------------------------------------------------------

### 4.5.1. Oral Administration of Sea Cucumber Saponins {#sec4dot5dot1-marinedrugs-14-00114}

20 mg/kg Echinoside A and Holotoxin A~1~ dissolved in water were, respectively, orally administered to the rats by gavage. Blood samples were collected from the orbital cavity at different times (5, 15, 30 min and 1, 2, 3, 4, 8, 12, and 24 h). The plasma was obtained from the blood samples by being centrifuged for 10 min at 4000 rpm, and then frozen at −20 °C prepared for analysis.

### 4.5.2. Intravenous Administration of Sea Cucumber Saponins {#sec4dot5dot2-marinedrugs-14-00114}

20 mg/kg Echinoside A and Holotoxin A~1~ dissolved in water were, respectively, orally administered to the rats by tail vein injection. Blood samples were collected from the orbital cavity at different times (5, 15, 30 min and 1, 2, 4, 8, 12, and 24 h). The plasma was separated and frozen at −20 °C and prepared for analysis.

We chose these parameters after we referred to other saponins. Doses of administration for saponins are different in previous research. Li *et al.* \[[@B37-marinedrugs-14-00114]\] investigated the pharmacokinetics of ilexsaponin A~1~ in rats, the dose of intravenous administration was 30 mg/kg. Odani *et al.* \[[@B38-marinedrugs-14-00114]\] investigated the pharmacokinetics of ginsenoside Rg~1~ in rats, the dose of intravenous administration was 5 mg/kg, and the dose of oral administration was 100 mg/kg. Lin *et al.* \[[@B39-marinedrugs-14-00114]\] investigated the pharmacokinetics of ginsenoside in rats, with the dose of oral administration being 50 mg/kg.

4.6. Caco-2 Cells Model {#sec4dot6-marinedrugs-14-00114}
-----------------------

### 4.6.1. Cell Culture {#sec4dot6dot1-marinedrugs-14-00114}

Caco-2 cells were cultured in DMEM supplemented with 20% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells were grown in a humidified atmosphere of 5% CO~2~ at 37 °C and were subcultured at 80%--90% confluency.

### 4.6.2. Transepithelial Transport Experiments {#sec4dot6dot2-marinedrugs-14-00114}

For transport studies, Caco-2 cells were seeded in Millicell (Corning) hanging cell culture inserts (0.33 cm^2^ surface, 0.4 μm pore size) at a density of 1 × 10^5^/cm^2^. The basolateral and apical compartments contained 1.0 and 0.5 mL of culture medium, respectively. Culture medium was replaced three times a week for 14 d, and daily thereafter. Cells with passage numbers 30--65 were used for transport experiments 19--30 d post-seeding. Monolayers with TEER value equal or above 300 Ω·cm^−2^ were selected for transport experiments.

The monolayers were washed twice with preheating transport medium (HBSS) and prei-ncubated for 30 min. Transport medium containing different concentration of sea cucumber saponins was added on either the apical (0.5 mL) or basolateral (1 mL) side while the receiver chamber contained corresponding volume of transport medium. Samples were collected from the receiver chamber after 30, 60, 90, 120, and 150 min. During the experiments, each sampling volume (300 μL) was replaced by an equal volume of blank transport medium. The relevant parameters were chosen according to previous research \[[@B30-marinedrugs-14-00114],[@B40-marinedrugs-14-00114],[@B41-marinedrugs-14-00114]\].

Samples collected from the receiver chamber were detected and the apparent permeability coefficients (Papp) were calculated. The absorption and transport of the drug in Caco-2 cell monolayer was evaluated by Papp. Propranolol and atenolol are typical drugs with high and low permeability on the Caco-2 cell monolayer. The Papp of propranolol and atenolol measured in this study were, respectively, (26.1 ± 1.2) × 10^−6^ and (0.48 ± 0.07) × 10^−6^ cm∙s^−1^, which was coincident with the literature \[[@B42-marinedrugs-14-00114],[@B43-marinedrugs-14-00114]\].

4.7. Single-Pass Intestinal Perfusion Model {#sec4dot7-marinedrugs-14-00114}
-------------------------------------------

The rats were anaesthetized with an intra-abdominal injection of 10% chloral hydrate at a dose of 5 mL/kg. The enterocoelia of the rat was dissected by a 3--4 cm midline length, a segment of intestine about 10 cm long was separated and washed with saline. Silicone tubing was inserted into both sides of the segment of intestine and a peristaltic pump was connected to the proximal side of the tube. A pledget with saline was added onto the surgical area to avoid loss of fluid. The segment was cleared with 37 °C saline firstly, then blank K-R buffer solution was infused at the inlet and blank perfusate was collected at the outlet. The segment was infused with perfusate containing phenol red and different concentrations of sea cucumber saponins (1, 5, and 25 μg/mL) at a flow rate of 2 mL/min. Then the rate was reduced to 0.2 mL/min for 30 min until steady-state. Samples were obtained from the outlet of the segment every 15 min and stored at −20 °C for analysis. Different concentrations of sea cucumber saponins were perfused to highlight the absorption mechanism of sea cucumber saponins, which were investigated by the concentration-dependent change of the permeability values. 400 μg/mL verapamil was added to the perfusion solution containing 5 μg/mL sea cucumber saponins and 20 μg/mL phenol red to investigate whether the intestinal absorption of sea cucumber saponins were affected by P-gp. The relevant parameters were chosen according to previous researches \[[@B18-marinedrugs-14-00114],[@B44-marinedrugs-14-00114]\].

4.8. Statistical Analysis {#sec4dot8-marinedrugs-14-00114}
-------------------------

Each experiment was carried out more than three individual times. The differences of AUC and *C*~max~ between Echinoside A and Holotoxin A~1~ after intravenous administration were assessed by a one-way analysis of variance (ANOVA) test using the SPSS (version 18.0, IBM SPSS Inc., Chicago, IL, USA). In the absorption transport experiment, two factor ANOVA for concentration and direction were used to compare the cumulative amounts in bidirectional transport. A pair-wise test was used to compare the Papp values of Echinoside A, Holotoxin A~1~, propranolol and atenolol. Differences were considered statistically significant at *p* \< 0.05.

5. Conclusions {#sec5-marinedrugs-14-00114}
==============

In this study, a highly-sensitive and effective HPLC method with evaporative light scattering detection was developed to determine sea cucumber saponins. This method was validated to confirm high accuracy, precision, and reproducibility. The method was successfully applied to the analysis in Caco-2 monolayer model, single-pass intestinal perfusion model, and *in vivo* pharmacokinetics in rats. The result indicated that Echinoside A showed higher bioavailability in rats than Holotoxin A~1~. In the Caco-2 monolayer model, the Papp value demonstrated efficient transport of Echinoside A and poor transport of Holotoxin A~1~, and the single-pass intestinal perfusion model confirmed high permeability of Echinoside A and poor permeability of Holotoxin A~1~. This study highlighted the absorption and transport of two sea cucumber saponin monomers, the relationship between the chemical structure of sea cucumber saponins and their bioavailability and the clinical application of sea cucumber saponins will be studied further in the future.
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![(**a**) Plasma concentrations-time curves of Echinoside A after oral administration; (**b**) plasma concentrations-time curves of Echinoside A after intravenous administration; and (**c**) plasma concentrations-time curves of Holotoxin A~1~ after intravenous administration. (means ± SD, *n* = 5).](marinedrugs-14-00114-g005){#marinedrugs-14-00114-f005}

![(**a**) AP-to-BL transport of different concentration of Echinoside A across Caco-2 monolayers; and (**b**) BL-to-AP transport of different concentration of Echinoside A across Caco-2 monolayers, (means ± SD, *n* = 3).](marinedrugs-14-00114-g006){#marinedrugs-14-00114-f006}

![Papp (AP to BL) value of Echinoside A, Holotoxin A~1~ and two transcellular transport markers, propranolol and atenolol, (means ± SD, *n* = 5). \* *p* \< 0.05, compared with propranolol; \# *p* \< 0.05, compared with atenolol.](marinedrugs-14-00114-g007){#marinedrugs-14-00114-f007}

![Peff values of Echinoside A and Holotoxin A~1~ at 1, 5, 25 μg/mL, as well as 50 μg/mL with the addition of verapamil using single-pass intestinal perfusion (means ± SD, *n* = 5).](marinedrugs-14-00114-g008){#marinedrugs-14-00114-f008}
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###### 

^1^H NMR and ^13^C NMR data for the aglycone moiety of Echinoside A.

  Position   δ~C~      δ~H~ (*J* in Hz)   Position   δ~C~      δ~H~ (*J* in Hz)
  ---------- --------- ------------------ ---------- --------- ------------------
  1          36.9 t    1.54 m             15         37.2 t    1.89 m
  1.88 m     1.42 m                                            
  2          27.6 t    1.90 m             16         36.4 t    2.37 d (11.7)
  2.14 m     2.70 m                                            
  3          89.2 d    3.39 d (10.9)      17         89.8 s    \-
  4          40.5s     \-                 18         175.3 s   \-
  5          53.2 d    1.10 s             19         23.5 q    1.28 s
  6          21.7 t    1.36 m             20         87.7 s    \-
  1.54 m     21        23.6 q             1.76 s               
  7          28.8 t    1.54 m             22         39.5 t    1.85 m
  1.76 m     23        22.8 t             1.80 m               
  8          41.4 d    3.39 d (10.9)      24         40.2 t    1.18 m
  9          154.5 s   \-                 25         28.5 d    1.54 m
  10         40.2 s    \-                 26         23.2 q    0.86 s
  11         116.1 d   5.63 d (4.2)       27         23.3 q    0.87 m
  12         71.8 d    5.05 m             30         28.5 q    1.28 s
  13         59.1 s    \-                 31         17.2 q    1.13 s
  14         46.9 s    \-                 32         20.6 q    1.70 s
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###### 

^1^H NMR and ^13^C NMR data for the sugar moiety of Echinoside A.

  Position   δ~C~     δ~H~ (*J* in Hz)   Position   δ~C~    δ~H~ (*J* in Hz)
  ---------- -------- ------------------ ---------- ------- ------------------
  Xyl        \-       \-                 Glc        \-      \-
  1          105.8    4.71               1          105.5   4.96
  2          83.8     4.02               2          72.2    4.02
  3          76.2     4.26               3          88.4    3.88
  4          74.4     5.12               4          65.3    4.23
  5          62.8 t   3.67               5          76.9    4.26
  4.40       6        61.3 t             4.30               
  \-         \-       \-                 4.55               
  Qui        \-       \-                 MeGlc      \-      \-
  1          105.9    5.05               1          106.2   5.32
  2          74.5     4.02               2          76.3    4.02
  3          75.6     4.17               3          89.8    4.23
  4          87.9     3.75               4          70.4    4.19
  5          71.9     3.75               5          78.5    3.88
  6          18.7     1.72               6          62.7    4.26
  \-         \-       \-                 OMe        61.3    3.86
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###### 

Intra- and inter-day precision and accuracy of Echinoside A and Holotoxin A~1~ measurements in rat plasma (*n* = 5).

  Compounds        Nominal Conc. (ng/mL)   Intra-Day       Inter-Day                                            
  ---------------- ----------------------- --------------- ----------- ----------------- --------------- ------ -----
  Echinoside A     100.00                  95.60 ± 4.90    −4.4        5.1               96.20 ± 5.08    −3.2   5.3
  1000.00          985.92 ± 27.51          −1.4            2.8         1023.65 ± 40.33   2.4             3.9    
  5000.00          4931.22 ± 94.00         −1.4            1.9         5112.43 ± 71.88   2.2             1.4    
  Holotoxin A~1~   100.00                  104.89 ± 7.60   4.9         7.2               105.75 ± 4.09   5.8    3.9
  1000.00          1029.80 ± 39.89         3.0             3.9         1030.41 ± 31.51   3.0             3.6    
  5000.00          4902.63 ± 114.78        −2.0            2.3         4826.33 ± 87.15   −3.5            1.8    
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###### 

Absolute recovery of the method for determining the concentration of Echinoside A and Holotoxin A~1~ in plasma samples (*n* = 5).

  Compounds        Concentration (ng/mL)   Absolute Recovery (mean ± SD %)   CV%
  ---------------- ----------------------- --------------------------------- ------
  Echinoside A     100                     91.30 ± 5.92                      8.70
  1000             94.74 ± 5.51            5.26                              
  5000             95.66 ± 4.08            4.34                              
  Holotoxin A~1~   100                     90.58 ± 6.72                      9.42
  1000             96.13 ± 4.55            3.87                              
  5000             95.96 ± 4.80            4.04                              

marinedrugs-14-00114-t005_Table 5

###### 

Stability of Echinoside A and Holotoxin A~1~ in rat plasma and perfusate (*n* = 5).

  Compounds        Nominal Conc. (ng/mL)   Accuracy (%)                                 
  ---------------- ----------------------- -------------- ------ ------- ------ ------- ------
  Echinoside A     100.00                  91.6           94.4   90.8    95.4   89.2    97.2
  1000.00          91.9                    96.7           91.3   96.0    92.6   102.1   
  5000.00          93.5                    98.9           94.4   102.4   91.1   100.3   
  Holotoxin A~1~   100.00                  88.2           93.4   92.7    96.2   92.4    94.7
  1000.00          92.1                    101.4          90.9   99.3    91.3   98.6    
  5000.00          94.3                    98.0           93.8   96.5    94.8   99.6    
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###### 

Pharmacokinetic parameters of Echinoside A and Holotoxin A~1~ after oral administration and intravenous administration (means ± SD, *n* = 5).

  Compounds        Administration   Pharmacokinetic Parameters                                     
  ---------------- ---------------- ---------------------------- --------------- ----------------- -------------
  Echinoside A     oral             6.9 ± 0.32                   3.0             0.91 ± 0.02       9.27 ± 0.39
  intravenous      8.52 ± 0.32      0.08                         4.0 ± 0.44 \*   16.43 ± 0.45 \*   
  Holotoxin A~1~   intravenous      4.4 ± 0.06                   0.08            2.87 ± 0.17       6.53 ± 0.15

\* *p* \< 0.05, compared with Holotoxin A~1~.
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###### 

Percentage of Echinoside A and Holotoxin A~1~ recovered in AP chambers, BL chambers, and cell monolayer (means ± SD, *n* = 5).

  Time (min)   Echinoside A   Recovery      Holotoxin A~1~                                         
  ------------ -------------- ------------- ---------------- -------------- -------------- ------- -------
  60           82.14 ± 2.85   1.04 ± 0.12   14.22 ± 1.14     97.40 ± 2.76   97.66 ± 2.02   \-      \-
  90           81.63 ± 2.04   1.51 ± 0.11   15.05 ± 1.29     98.19 ± 1.97   96.56 ± 1.89   \-      \-
  120          80.25 ± 2.67   1.90 ± 0.20   14.43 ± 1.24     96.58 ± 2.33   95.46 ± 1.72   \-      \-
  150          79.38 ± 2.21   2.36 ± 0.21   14.78 ± 0.92     96.52 ± 2.04   95.90 ± 2.27   \<0.2   \<0.2
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###### 

Values of apparent permeability coefficients (Papp) and efflux ratios in the absence and presence of verapamil (means ± SD, *n* = 5).

  Compounds                            Papp (× 10^−6^, cm·s^−1^)   Efflux Ratio   
  ------------------------------------ --------------------------- -------------- -------------
  Echinoside A (20 μM)                 3.96 ± 0.55                 5.38 ± 0.81    1.36 ± 0.17
  Echinoside A (20 μM) + verapamil     4.04 ± 0.39                 5.33 ± 0.70    1.32 ± 0.16
  Holotoxin A~1~ (18 μM)               \<0.83                      \<0.83         \-
  Holotoxin A~1~ (18 μM) + verapamil   \<0.83                      \<0.83         \-
